A global ecosystem that accelerates psychedelic innovation by investing in research & education.
Thank you for your interest in PsychedeliTech.
PsychedeliTech will create a global ecosystem to accelerate psychedelic innovation by investing in research, education and clinical trials of psychedelic medicine.
Decriminalization and/or deregulation of psychedelic substances is starting to gain momentum. Accredited US and European research institutions are developing a growing body of scientific knowledge based on compelling clinical research that will have major impact on global mental health. At iCAN, we believe that cannabis has provided a road-map for the emerging psychedelics market and we are excited to be early in the plant-based medicine space. PsychedeliTech will create a global ecosystem that accelerates psychedelic innovation by investing in research, education and clinical trials leading to effective clinical practices and products.
The documents below explain the PsychedeliTech investment opportunity. After review, complete the form below for more information.